© 1994 Oxford University Press
OTHER |
Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystropothhy
1School of Biological Sciences, 3.239 Stopford Building. University of Manchester Oxford Road, Manchester M13 9PT 2Department of Biochemistry and Molecula Genetics, St Mary's Hospital Medical School, Imperial College of Science, Technonology and Medicine London W2 1PG, UK 3MGC-Department of Human Genetics, Leiden University 2333 AL Leiden, the Netherlands 4Genome Analysis, ICRF, 44 Lincoln's Inn Fields London WC2 3PX 5Department of Craniofacial Development, UMDS, Guy's Hospital London Bridge, London SE1 9RT, UK
*To whom correspondence should be addressed at: School of Biological Sciences, 3.239 Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK
Received March 30, 1994; Accepted May 16, 1994
The sequence of the tandem repeat sequence (D4Z4) associated with facioscapulohumeral muscular dystrophy (FSHD) has been determined: each copy of the 3.3 kb repeat contains two homeoboxes and two previously described repetitive sequences, LSau and a GC-rich low copy repeat designated hhspm3. By Southern blotting, FISH and isolation of cDNA and genomic clones we show that there are repeat sequences similar to D4Z4 at other locations in the human genome. Southern blot analysis of primate genomic DNA indicates that the copy number of D4Z4-like repeats has increased markedly within the last 25 million years. Two cDNA clones were isolated and found to contain stop codons and frameshifts within the homeodomains. An STS was produced to the cDNAs and analysis of a somatic cell hybrid panel suggests they map to chromosome 14. No cDNA clones mapping to the chromosome 4q35 D4Z4 repeats have been Identified, although the possiblilty that they encode a protein cannot be ruled out. Although D4Z4 may not encode a protein, there is an association between deletions within this locus and FSHD. The D4Z4 repeats contain LSau repeats and are adjacent to 68 bp Sau3A repeats. Both of these sequences are associated with heterochromatic regions of DNA, regions known to be involved in the phenomenon of position effect variegation. We postulate that deletion of D4Z4 sequences could produce a position effect.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. Arashiro, I. Eisenberg, A. T. Kho, A. M. P. Cerqueira, M. Canovas, H. C. A. Silva, R. C. M. Pavanello, S. Verjovski-Almeida, L. M. Kunkel, and M. Zatz Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers PNAS, April 14, 2009; 106(15): 6220 - 6225. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Chadwick DXZ4 chromatin adopts an opposing conformation to that of the surrounding chromosome and acquires a novel inactive X-specific role involving CTCF and antisense transcripts Genome Res., August 1, 2008; 18(8): 1259 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dixit, E. Ansseau, A. Tassin, S. Winokur, R. Shi, H. Qian, S. Sauvage, C. Matteotti, A. M. van Acker, O. Leo, et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1 PNAS, November 13, 2007; 104(46): 18157 - 18162. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Osborne, S. Welle, S. L. Venance, C. A. Thornton, and R. Tawil Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy Neurology, February 20, 2007; 68(8): 569 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Petrov, I. Pirozhkova, G. Carnac, D. Laoudj, M. Lipinski, and Y. S. Vassetzky Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts PNAS, May 2, 2006; 103(18): 6982 - 6987. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diab, B. T. Darras, and F. Shapiro Scapulothoracic Fusion for Facioscapulohumeral Muscular Dystrophy J. Bone Joint Surg. Am., October 1, 2005; 87(10): 2267 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Rijkers, G Deidda, S van Koningsbruggen, M van Geel, R J L F Lemmers, J C T van Deutekom, D Figlewicz, J E Hewitt, G W Padberg, R R Frants, et al. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients J. Med. Genet., November 1, 2004; 41(11): 826 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tam, K. P. Smith, and J. B. Lawrence The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres J. Cell Biol., October 25, 2004; 167(2): 269 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Masny, U. Bengtsson, S.-A. Chung, J. H. Martin, B. van Engelen, S. M. van der Maarel, and S. T. Winokur Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? Hum. Mol. Genet., September 1, 2004; 13(17): 1857 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Cardone, L. Ballarati, M. Ventura, M. Rocchi, A. Marozzi, E. Ginelli, and R. Meneveri Evolution of Beta Satellite DNA Sequences: Evidence for Duplication-Mediated Repeat Amplification and Spreading Mol. Biol. Evol., September 1, 2004; 21(9): 1792 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jiang, F. Yang, P. G. M. van Overveld, V. Vedanarayanan, S. van der Maarel, and M. Ehrlich Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q Hum. Mol. Genet., November 15, 2003; 12(22): 2909 - 2921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Winokur, Y.-W. Chen, P. S. Masny, J. H. Martin, J. T. Ehmsen, S. J. Tapscott, S. M. van der Maarel, Y. Hayashi, and K. M. Flanigan Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation Hum. Mol. Genet., November 15, 2003; 12(22): 2895 - 2907. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Felice, W. A. North, S. A. Moore, and K. D. Mathews FSH dystrophy 4q35 deletion in patients presenting with facial-sparing scapular myopathy Neurology, May 23, 2000; 54(10): 1927 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kondo, M. P. Bobek, R. Kuick, B. Lamb, X. Zhu, A. Narayan, D. Bourc'his, E. Viegas-Pequignot, M. Ehrlich, and S. M. Hanash Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2 Hum. Mol. Genet., March 1, 2000; 9(4): 597 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tupler, G. Perini, M. A. Pellegrino, and M. R. Green Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy PNAS, October 26, 1999; 96(22): 12650 - 12654. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Orrell, R. Tawil, J. Forrester, J. T. Kissel, J. R. Mendell, and D. A. Figlewicz Definitive molecular diagnosis of facioscapulohumeral dystrophy Neurology, June 1, 1999; 52(9): 1822 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mazzarella and D. Schlessinger Pathological Consequences of Sequence Duplications in the Human Genome Genome Res., October 1, 1998; 8(10): 1007 - 1021. [Abstract] [Full Text] |
||||
![]() |
S. M. Purandare and P. I. Patel Recombination Hot Spots and Human Disease Genome Res., August 1, 1997; 7(8): 773 - 786. [Full Text] [PDF] |
||||
![]() |
A.H.M. M. Huq, J. S. Sutcliffe, M. Nakao, Y. Shen, R. A. Gibbs, and A. L. Beaudet Sequencing and Functional Analysis of the SNRPN Promoter: In Vitro Methylation Abolishes Promoter Activity Genome Res., June 1, 1997; 7(6): 642 - 648. [Abstract] [Full Text] [PDF] |
||||







